article thumbnail

207 community hospital presidents and CEOs to know | 2025

Beckers Hospital Review

She has held her position since 2002. He directed major infrastructure projects, including a new emergency department triage unit, observation unit, state-of-the-art cath lab and inpatient pharmacy, while implementing tools like EndoTool to improve diabetes care safety. In 2020, the organization recognized Ms.

Hospitals 125
article thumbnail

FDA green lights CSL's once-monthly HAE drug Andembry

pharmaphorum

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lupin acquires nine brands of Medical Nutritional Institute in South Africa

Express Pharma

This acquisition broadens our product range by concentrating on metabolic diseases such as cardiovascular disease, diabetes, and neuroscience, thereby enhancing patient health and well-being.” Mariaan du Plessis, CEO of MNI , shared her excitement about joining Pharma Dynamics. “We

article thumbnail

PharmaShots Weekly Snapshots (March 27 - 31, 2023)

PharmaShots

PDS Biotech to Initiate P-III Trial (VERSATILE-003) of PDS0101 + Keytruda (pembrolizumab) for Head and Neck Cancer Date: Mar 31, 2023 | Tags: PDS Biotech, PDS0101, Keytruda, pembrolizumab, Head, Neck Cancer, Clinical Trial, P-III, VERSATILE-003 Trial Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular (..)

article thumbnail

Minority Health: The Importance of Patient Navigation and Access to Timely Care

Putting Patients First Blog

Washington (DC): National Academies Press (US); 2002. Similar patient experiences are supported by the 2003 Institute of Medicine’s (IOM) findings in Unequal Treatment that documented disparities in clinical interventions. 2 Unfortunately, health outcome indicators are still demonstrating inequities. [link]. DOI: [link].

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events. Diabetic Neuropathy Diabetic neuropathy, a common complication of long-term high blood sugar and insulin resistance, can cause constipation. Curr Opin Endocrinol Diabetes Obes.

article thumbnail

The Ultimate Guide To Using Enzymes with Hashimoto’s

The Thyroid Pharmacist

A poster presentation from April 21-24, 2002 presented in Cannes, France, found that Wobenzym , a proprietary blend of systemic enzymes, taken at a dose of five capsules, three times per day, showed very promising results in Hashimoto’s. ( * Wobenzym N is the formulation that was studied. Diabetic nephropathy. Joint pain. Inflammation.